On Monday, Xerox Corp (NYSE:XRX)’s shares inclined 1.55% to $10.51.
To assist businesses and government better secure products as they are distributed, Xerox (XRX) recently introduced two printed electronic labels that can collect and store information about the authenticity and condition of products.
Xerox Printed Memory is a highly secure, printed label containing up to 36 bits of rewritable memory which can store up to 68 billion points of data. The labels, for example, can be used to determine if a product is genuine and to track how it’s been handled during distribution.
The second product, Xerox Printed Memory with Cryptographic Security comprises a unique, encrypted printed code (such as a QR bar code) to the memory. It can only be read by authorized personnel using a reader which interfaces with a secure smartphone application. This combination of printed memory with an encrypted printed code, creates one of the most secure anti-counterfeit solutions on the market. It is ideal for use in applications as wide ranging as tracking and ensuring the safety of pharmaceutical products to securing tax or duty stamps for government agencies. The cryptographic security feature was developed at PARC, A Xerox company, and is an added feature in the printed memory labels.
Xerox Corporation provides business process and document administration solutions worldwide. The company’s Services segment offers various business process outsourcing services, such as customer care, transaction processing, human resources, communication and marketing, and consulting and analytics services, in addition to finance, accounting, and procurement services.
Medtronic PLC (NYSE:MDT)’s shares dropped -0.13% to $70.24.
Medtronic plc (MDT) declared the U.S. launch of the Arc(TM) support catheter, the most navigable, 6F tapered support catheter accessible. Developed to improve delivery of Medtronic`s Solitaire(TM) stent retriever, the Arc support catheter provides the fastest route to restoration of blood flow in patients with complex anatomy suffering acute ischemic stroke.1,2,3 The Arc catheter series received U.S. Food and Drug Administration 510(K) clearance in July 2015.
Recently, the American Heart Association/American Stroke Association (AHA/ASA) published new stroke treatment guidelines that recommend the use of stent retriever technology - such as Medtronic`s Solitaire stent retriever device - in conjunction with the current standard of care, IV-tPA for eligible patients. The AHA/ASA guidelines are based on a panel of experts` analysis of the results from five global clinical trials published in The New England Journal of Medicine (NEJM) that found the addition of stent retriever technology, a surgical procedure that manually removes blood clots from the brain, to current medical therapy such as IV-tPA, has a therapeutic benefit over medical therapy alone.
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators, implantable cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, and peripheral vascular intervention products.
At the end of Monday’s trade, Danaher Corporation (NYSE:DHR)‘s shares surged 0.24% to $86.42.
Danaher Corporation (DHR) declared that its Board of Directors has approved a regular quarterly dividend of $0.135 per share payable on October 30, 2015 to holders of record on September 25, 2015.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; hardware and software solutions to deploy, manage, and secure communication network technologies and services; and tools, toolboxes, and automotive maintenance equipment.
KB Home (NYSE:KBH), ended its Monday’s trading session with -1.84% loss, and closed at $14.44.
KB Home (KBH), one of the nation’s largest and most recognized homebuilders, recently declared that Jay Lewis has been named president of its Orlando division. In this role, Lewis is responsible for the Company’s homebuilding operations across the region, from land acquisition and construction to sales and customer service.
Lewis arrives at KB Home with more than 30 years of experience in homebuilding with both national and local builders, counting the last eight years in the Central Florida area serving in various capacities. He holds a Bachelor of Science degree in business administration from Villanova University and a Master of Business Administration from Drexel University.
KB Home operates as a homebuilding company in the United States. It constructs and sells various homes, counting attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers under the name KB Home.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
